1. Home
  2. AMPH vs CGBD Comparison

AMPH vs CGBD Comparison

Compare AMPH & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.31

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$11.60

Market Cap

826.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
CGBD
Founded
1996
2012
Country
United States
United States
Employees
N/A
2500
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
971.8M
826.2M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
CGBD
Price
$19.31
$11.60
Analyst Decision
Buy
Hold
Analyst Count
8
8
Target Price
$28.38
$12.92
AVG Volume (30 Days)
371.8K
720.8K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
14.42%
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$719,887,000.00
N/A
Revenue This Year
$6.90
$3.74
Revenue Next Year
$4.64
$1.80
P/E Ratio
$11.87
$10.36
Revenue Growth
N/A
N/A
52 Week Low
$17.03
$10.64
52 Week High
$31.26
$14.48

Technical Indicators

Market Signals
Indicator
AMPH
CGBD
Relative Strength Index (RSI) 36.58 49.38
Support Level $18.92 $11.19
Resistance Level $20.08 $13.06
Average True Range (ATR) 0.80 0.29
MACD -0.03 -0.00
Stochastic Oscillator 14.80 36.45

Price Performance

Historical Comparison
AMPH
CGBD

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: